Top compounds associated with response to P2RY2


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.33 2e-21
mRNA ATRA CTRPv2 pan-cancer AAC 0.27 3e-14
mRNA lapatinib CCLE pan-cancer AAC 0.35 1e-12
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 5e-12
mRNA Erlotinib CCLE pan-cancer AAC 0.34 6e-12
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-11
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.3 5e-09
mRNA canertinib CTRPv2 pan-cancer AAC 0.22 7e-09
mRNA KIN001-055 GDSC1000 pan-cancer AAC 0.21 9e-09
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.22 3e-08
Download CSV